Literature DB >> 35896190

Ibogaine microdosing in a patient with bipolar depression: a case report.

Maria Helha Fernandes-Nascimento1, Karine Viana-Ferreira2, Bruno Daniel Rasmussen Chaves3, André Brooking Negrão4, Yuan-Pang Wang1.   

Abstract

Entities:  

Year:  2022        PMID: 35896190      PMCID: PMC9375667          DOI: 10.47626/1516-4446-2021-2359

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446


× No keyword cloud information.
  4 in total

1.  Treating drug dependence with the aid of ibogaine: a retrospective study.

Authors:  Eduardo Ekman Schenberg; Maria Angélica de Castro Comis; Bruno Rasmussen Chaves; Dartiu Xavier da Silveira
Journal:  J Psychopharmacol       Date:  2014-09-29       Impact factor: 4.153

2.  A non-hallucinogenic psychedelic analogue with therapeutic potential.

Authors:  Lindsay P Cameron; Robert J Tombari; Ju Lu; Alexander J Pell; Zefan Q Hurley; Yann Ehinger; Maxemiliano V Vargas; Matthew N McCarroll; Jack C Taylor; Douglas Myers-Turnbull; Taohui Liu; Bianca Yaghoobi; Lauren J Laskowski; Emilie I Anderson; Guoliang Zhang; Jayashri Viswanathan; Brandon M Brown; Michelle Tjia; Lee E Dunlap; Zachary T Rabow; Oliver Fiehn; Heike Wulff; John D McCorvy; Pamela J Lein; David Kokel; Dorit Ron; Jamie Peters; Yi Zuo; David E Olson
Journal:  Nature       Date:  2020-12-09       Impact factor: 49.962

3.  Self-blinding citizen science to explore psychedelic microdosing.

Authors:  Balázs Szigeti; Laura Kartner; Allan Blemings; Fernando Rosas; Amanda Feilding; David J Nutt; Robin L Carhart-Harris; David Erritzoe
Journal:  Elife       Date:  2021-03-02       Impact factor: 8.140

Review 4.  Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.

Authors:  Joost J Breeksema; Alistair R Niemeijer; Erwin Krediet; Eric Vermetten; Robert A Schoevers
Journal:  CNS Drugs       Date:  2020-09       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.